LOXIMVI - Cell Line (ID:50988)

HMS LINCS ID: 50988
Name: LOXIMVI
Alternative Names: LOX IMVI
LINCS ID: LCL-1276
Alternative ID: CLO_0037130
Parent Cell Line:
Reference Source: DTP, DCTD Tumor Repository, National Cancer Institute
Organism: Homo sapiens
Organ: skin
Tissue:
Cell Type:
Details of Cell Type:
Donor Sex: male
Donor Age:
Donor Ethnicity:
Donor Health Status:
Disease: DOID:1909, malignant melanoma
Details of Disease: malignant melanoma; metastatic
Production Details:
Genetic Modification(s): none
Known Mutations:
Citation Information for Mutations: COSS905974
Verification Reference Profile:
Growth Properties: semi-adherent
Recommended Culture Conditions:
Relevant Citations:
Usage Note:
Comments:
Date Publicly Available: 2012-07-31
Most Recent Update: 2016-07-12

Datasets:

HMS Dataset ID Dataset Title HMS Dataset Type
20217
Viability and apoptosis in BRAF(V600E/D) melanoma cell lines monitored by imaging
Microscopy/Imaging
20218
Phosphorylation state and protein levels measured in BRAF(V600E/D) melanoma cell lines monitored by Reverse Phase Protein Arrays (RPPA)
Reverse Phase Protein Array
20219
Phosphorylation state and protein levels measured in BRAF(V600E/D) melanoma cell lines monitored by imaging
Microscopy/Imaging
20229
PLSR model loadings (pMEK and pERK included) from analysis of the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines
Analysis
20230
PLSR model loadings (pMEK and pERK excluded) from analysis of the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines
Analysis
20231
Average variable importance in the projection (VIP) scores from the PLSR models analyzing the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines
Analysis

Batch Information:

HMS LINCS Batch ID Provider Provider Catalog ID Provider Batch ID
50988-1 Nathan Moerke (Harvard Medical School)
50988-2 Nathan Moerke (Harvard Medical School)